nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—ABCB1—colon cancer	0.296	1	CbGaD
Aripiprazole—CYP3A7—Irinotecan—colon cancer	0.0412	0.145	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0412	0.145	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.036	0.127	CbGbCtD
Aripiprazole—CYP3A7—Vincristine—colon cancer	0.036	0.127	CbGbCtD
Aripiprazole—CYP3A5—Irinotecan—colon cancer	0.0309	0.109	CbGbCtD
Aripiprazole—CYP3A5—Vincristine—colon cancer	0.027	0.0954	CbGbCtD
Aripiprazole—ABCB1—Irinotecan—colon cancer	0.0201	0.071	CbGbCtD
Aripiprazole—ABCB1—Vincristine—colon cancer	0.0176	0.0621	CbGbCtD
Aripiprazole—HTR3A—myenteric nerve plexus—colon cancer	0.013	0.118	CbGeAlD
Aripiprazole—CYP3A4—Irinotecan—colon cancer	0.012	0.0425	CbGbCtD
Aripiprazole—ABCB1—Methotrexate—colon cancer	0.0106	0.0376	CbGbCtD
Aripiprazole—CYP3A4—Vincristine—colon cancer	0.0105	0.0372	CbGbCtD
Aripiprazole—CHRM3—ureter—colon cancer	0.0102	0.093	CbGeAlD
Aripiprazole—HTR7—myenteric nerve plexus—colon cancer	0.00839	0.0762	CbGeAlD
Aripiprazole—CHRM3—muscle of abdomen—colon cancer	0.00737	0.0669	CbGeAlD
Aripiprazole—HTR7—vein—colon cancer	0.00541	0.0491	CbGeAlD
Aripiprazole—HTR2A—myenteric nerve plexus—colon cancer	0.00523	0.0475	CbGeAlD
Aripiprazole—HTR2A—vein—colon cancer	0.00337	0.0306	CbGeAlD
Aripiprazole—HTR1B—blood vessel—colon cancer	0.00223	0.0202	CbGeAlD
Aripiprazole—HTR1D—blood vessel—colon cancer	0.00215	0.0196	CbGeAlD
Aripiprazole—HTR7—endothelium—colon cancer	0.00186	0.0169	CbGeAlD
Aripiprazole—HTR7—blood vessel—colon cancer	0.00172	0.0156	CbGeAlD
Aripiprazole—H1F0—embryo—colon cancer	0.00166	0.0151	CbGeAlD
Aripiprazole—CHRM5—epithelium—colon cancer	0.00157	0.0142	CbGeAlD
Aripiprazole—DRD5—lymphoid tissue—colon cancer	0.00135	0.0122	CbGeAlD
Aripiprazole—ADRA1B—renal system—colon cancer	0.00133	0.0121	CbGeAlD
Aripiprazole—H1F0—smooth muscle tissue—colon cancer	0.0013	0.0118	CbGeAlD
Aripiprazole—H1F0—renal system—colon cancer	0.00126	0.0114	CbGeAlD
Aripiprazole—HTR2A—endothelium—colon cancer	0.00116	0.0105	CbGeAlD
Aripiprazole—HTR2A—blood vessel—colon cancer	0.00107	0.00972	CbGeAlD
Aripiprazole—H1F0—lymphoid tissue—colon cancer	0.00104	0.00947	CbGeAlD
Aripiprazole—CYP3A7—liver—colon cancer	0.00103	0.00939	CbGeAlD
Aripiprazole—H1F0—digestive system—colon cancer	0.00103	0.00935	CbGeAlD
Aripiprazole—HTR3A—digestive system—colon cancer	0.000982	0.00892	CbGeAlD
Aripiprazole—H1F0—bone marrow—colon cancer	0.000949	0.00862	CbGeAlD
Aripiprazole—HTR2B—smooth muscle tissue—colon cancer	0.00094	0.00853	CbGeAlD
Aripiprazole—H1F0—vagina—colon cancer	0.000909	0.00826	CbGeAlD
Aripiprazole—CYP3A7-CYP3A51P—liver—colon cancer	0.00088	0.00799	CbGeAlD
Aripiprazole—CHRM3—smooth muscle tissue—colon cancer	0.000846	0.00768	CbGeAlD
Aripiprazole—HTR7—epithelium—colon cancer	0.000835	0.00758	CbGeAlD
Aripiprazole—CHRM3—renal system—colon cancer	0.000814	0.00739	CbGeAlD
Aripiprazole—HTR1A—renal system—colon cancer	0.000811	0.00736	CbGeAlD
Aripiprazole—ADRA1A—epithelium—colon cancer	0.000806	0.00731	CbGeAlD
Aripiprazole—HTR7—smooth muscle tissue—colon cancer	0.000805	0.00731	CbGeAlD
Aripiprazole—HTR7—renal system—colon cancer	0.000775	0.00703	CbGeAlD
Aripiprazole—H1F0—liver—colon cancer	0.000767	0.00697	CbGeAlD
Aripiprazole—SLC6A4—digestive system—colon cancer	0.000749	0.0068	CbGeAlD
Aripiprazole—ADRA1A—renal system—colon cancer	0.000747	0.00678	CbGeAlD
Aripiprazole—HTR2B—digestive system—colon cancer	0.000742	0.00674	CbGeAlD
Aripiprazole—KCNH2—renal system—colon cancer	0.000722	0.00655	CbGeAlD
Aripiprazole—ADRA2C—renal system—colon cancer	0.000712	0.00647	CbGeAlD
Aripiprazole—ABCB1—blood vessel—colon cancer	0.000701	0.00637	CbGeAlD
Aripiprazole—CHRM3—digestive system—colon cancer	0.000668	0.00606	CbGeAlD
Aripiprazole—HTR2B—vagina—colon cancer	0.000655	0.00595	CbGeAlD
Aripiprazole—HTR2A—embryo—colon cancer	0.000638	0.0058	CbGeAlD
Aripiprazole—HTR7—digestive system—colon cancer	0.000636	0.00577	CbGeAlD
Aripiprazole—HRH1—epithelium—colon cancer	0.000624	0.00566	CbGeAlD
Aripiprazole—ADRA1A—lymphoid tissue—colon cancer	0.000621	0.00563	CbGeAlD
Aripiprazole—HRH1—smooth muscle tissue—colon cancer	0.000601	0.00546	CbGeAlD
Aripiprazole—CYP3A5—renal system—colon cancer	0.000596	0.00541	CbGeAlD
Aripiprazole—H1F0—lymph node—colon cancer	0.000588	0.00534	CbGeAlD
Aripiprazole—KCNH2—bone marrow—colon cancer	0.000546	0.00495	CbGeAlD
Aripiprazole—KCNH2—vagina—colon cancer	0.000523	0.00475	CbGeAlD
Aripiprazole—HTR2A—epithelium—colon cancer	0.000521	0.00473	CbGeAlD
Aripiprazole—ADRA2C—vagina—colon cancer	0.000516	0.00468	CbGeAlD
Aripiprazole—HTR2A—smooth muscle tissue—colon cancer	0.000502	0.00456	CbGeAlD
Aripiprazole—CYP3A5—digestive system—colon cancer	0.000489	0.00444	CbGeAlD
Aripiprazole—HTR2A—renal system—colon cancer	0.000483	0.00439	CbGeAlD
Aripiprazole—HRH1—digestive system—colon cancer	0.000475	0.00431	CbGeAlD
Aripiprazole—HTR7—liver—colon cancer	0.000473	0.0043	CbGeAlD
Aripiprazole—ADRA1A—liver—colon cancer	0.000457	0.00415	CbGeAlD
Aripiprazole—CYP3A4—renal system—colon cancer	0.000447	0.00406	CbGeAlD
Aripiprazole—CYP2D6—renal system—colon cancer	0.00044	0.004	CbGeAlD
Aripiprazole—ADRA2C—liver—colon cancer	0.000435	0.00395	CbGeAlD
Aripiprazole—CYP3A5—vagina—colon cancer	0.000432	0.00392	CbGeAlD
Aripiprazole—HTR2B—lymph node—colon cancer	0.000424	0.00385	CbGeAlD
Aripiprazole—HRH1—vagina—colon cancer	0.000419	0.0038	CbGeAlD
Aripiprazole—ABCB1—embryo—colon cancer	0.000418	0.0038	CbGeAlD
Aripiprazole—ADRA2A—vagina—colon cancer	0.000412	0.00374	CbGeAlD
Aripiprazole—HTR2A—digestive system—colon cancer	0.000396	0.0036	CbGeAlD
Aripiprazole—CYP3A4—digestive system—colon cancer	0.000367	0.00333	CbGeAlD
Aripiprazole—CYP3A5—liver—colon cancer	0.000364	0.00331	CbGeAlD
Aripiprazole—CYP2D6—digestive system—colon cancer	0.000361	0.00328	CbGeAlD
Aripiprazole—HTR2A—vagina—colon cancer	0.00035	0.00318	CbGeAlD
Aripiprazole—ABCB1—epithelium—colon cancer	0.000341	0.0031	CbGeAlD
Aripiprazole—KCNH2—lymph node—colon cancer	0.000338	0.00307	CbGeAlD
Aripiprazole—ADRA2C—lymph node—colon cancer	0.000334	0.00303	CbGeAlD
Aripiprazole—ABCB1—renal system—colon cancer	0.000317	0.00287	CbGeAlD
Aripiprazole—HTR2A—liver—colon cancer	0.000295	0.00268	CbGeAlD
Aripiprazole—CYP3A4—liver—colon cancer	0.000273	0.00248	CbGeAlD
Aripiprazole—HRH1—lymph node—colon cancer	0.000271	0.00246	CbGeAlD
Aripiprazole—CYP2D6—liver—colon cancer	0.000269	0.00244	CbGeAlD
Aripiprazole—ADRA2A—lymph node—colon cancer	0.000266	0.00242	CbGeAlD
Aripiprazole—ABCB1—lymphoid tissue—colon cancer	0.000263	0.00239	CbGeAlD
Aripiprazole—ABCB1—digestive system—colon cancer	0.00026	0.00236	CbGeAlD
Aripiprazole—ABCB1—bone marrow—colon cancer	0.000239	0.00217	CbGeAlD
Aripiprazole—ABCB1—vagina—colon cancer	0.000229	0.00208	CbGeAlD
Aripiprazole—ABCB1—liver—colon cancer	0.000193	0.00176	CbGeAlD
Aripiprazole—Mood swings—Methotrexate—colon cancer	0.000182	0.000607	CcSEcCtD
Aripiprazole—Hypotension—Vincristine—colon cancer	0.000182	0.000606	CcSEcCtD
Aripiprazole—Bradycardia—Capecitabine—colon cancer	0.000182	0.000606	CcSEcCtD
Aripiprazole—Anaphylactic shock—Fluorouracil—colon cancer	0.000182	0.000605	CcSEcCtD
Aripiprazole—Oedema—Fluorouracil—colon cancer	0.000182	0.000605	CcSEcCtD
Aripiprazole—Anorexia—Irinotecan—colon cancer	0.000181	0.000602	CcSEcCtD
Aripiprazole—Ataxia—Methotrexate—colon cancer	0.000181	0.000602	CcSEcCtD
Aripiprazole—Infection—Fluorouracil—colon cancer	0.00018	0.000601	CcSEcCtD
Aripiprazole—Haemoglobin—Capecitabine—colon cancer	0.000179	0.000598	CcSEcCtD
Aripiprazole—Rhinitis—Capecitabine—colon cancer	0.000179	0.000597	CcSEcCtD
Aripiprazole—Haemorrhage—Capecitabine—colon cancer	0.000179	0.000595	CcSEcCtD
Aripiprazole—Hepatitis—Capecitabine—colon cancer	0.000179	0.000595	CcSEcCtD
Aripiprazole—Nervous system disorder—Fluorouracil—colon cancer	0.000178	0.000593	CcSEcCtD
Aripiprazole—Thrombocytopenia—Fluorouracil—colon cancer	0.000178	0.000592	CcSEcCtD
Aripiprazole—Hypoaesthesia—Capecitabine—colon cancer	0.000178	0.000592	CcSEcCtD
Aripiprazole—Liver function test abnormal—Methotrexate—colon cancer	0.000177	0.000591	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Vincristine—colon cancer	0.000177	0.000591	CcSEcCtD
Aripiprazole—Pharyngitis—Capecitabine—colon cancer	0.000177	0.000591	CcSEcCtD
Aripiprazole—Tachycardia—Fluorouracil—colon cancer	0.000177	0.000591	CcSEcCtD
Aripiprazole—Hypotension—Irinotecan—colon cancer	0.000177	0.00059	CcSEcCtD
Aripiprazole—Urinary tract disorder—Capecitabine—colon cancer	0.000176	0.000588	CcSEcCtD
Aripiprazole—Insomnia—Vincristine—colon cancer	0.000176	0.000587	CcSEcCtD
Aripiprazole—Oedema peripheral—Capecitabine—colon cancer	0.000176	0.000586	CcSEcCtD
Aripiprazole—Connective tissue disorder—Capecitabine—colon cancer	0.000175	0.000585	CcSEcCtD
Aripiprazole—Urethral disorder—Capecitabine—colon cancer	0.000175	0.000583	CcSEcCtD
Aripiprazole—Paraesthesia—Vincristine—colon cancer	0.000175	0.000583	CcSEcCtD
Aripiprazole—Breast disorder—Methotrexate—colon cancer	0.000174	0.000579	CcSEcCtD
Aripiprazole—Anorexia—Fluorouracil—colon cancer	0.000173	0.000577	CcSEcCtD
Aripiprazole—Visual impairment—Capecitabine—colon cancer	0.000172	0.000574	CcSEcCtD
Aripiprazole—Insomnia—Irinotecan—colon cancer	0.000171	0.000571	CcSEcCtD
Aripiprazole—Paraesthesia—Irinotecan—colon cancer	0.00017	0.000567	CcSEcCtD
Aripiprazole—Hypotension—Fluorouracil—colon cancer	0.00017	0.000565	CcSEcCtD
Aripiprazole—Decreased appetite—Vincristine—colon cancer	0.000169	0.000564	CcSEcCtD
Aripiprazole—Dyspnoea—Irinotecan—colon cancer	0.000169	0.000563	CcSEcCtD
Aripiprazole—Somnolence—Irinotecan—colon cancer	0.000169	0.000562	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Vincristine—colon cancer	0.000168	0.00056	CcSEcCtD
Aripiprazole—Fatigue—Vincristine—colon cancer	0.000168	0.000559	CcSEcCtD
Aripiprazole—Eye disorder—Capecitabine—colon cancer	0.000167	0.000556	CcSEcCtD
Aripiprazole—Dyspepsia—Irinotecan—colon cancer	0.000167	0.000556	CcSEcCtD
Aripiprazole—Tinnitus—Capecitabine—colon cancer	0.000166	0.000555	CcSEcCtD
Aripiprazole—Pain—Vincristine—colon cancer	0.000166	0.000555	CcSEcCtD
Aripiprazole—Constipation—Vincristine—colon cancer	0.000166	0.000555	CcSEcCtD
Aripiprazole—Asthma—Methotrexate—colon cancer	0.000166	0.000554	CcSEcCtD
Aripiprazole—Cardiac disorder—Capecitabine—colon cancer	0.000166	0.000552	CcSEcCtD
Aripiprazole—Flushing—Capecitabine—colon cancer	0.000166	0.000552	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000165	0.000551	CcSEcCtD
Aripiprazole—Decreased appetite—Irinotecan—colon cancer	0.000165	0.000549	CcSEcCtD
Aripiprazole—Eosinophilia—Methotrexate—colon cancer	0.000164	0.000548	CcSEcCtD
Aripiprazole—Insomnia—Fluorouracil—colon cancer	0.000164	0.000547	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Irinotecan—colon cancer	0.000164	0.000545	CcSEcCtD
Aripiprazole—Fatigue—Irinotecan—colon cancer	0.000163	0.000545	CcSEcCtD
Aripiprazole—Paraesthesia—Fluorouracil—colon cancer	0.000163	0.000543	CcSEcCtD
Aripiprazole—Pancreatitis—Methotrexate—colon cancer	0.000163	0.000543	CcSEcCtD
Aripiprazole—Pain—Irinotecan—colon cancer	0.000162	0.00054	CcSEcCtD
Aripiprazole—Constipation—Irinotecan—colon cancer	0.000162	0.00054	CcSEcCtD
Aripiprazole—Angiopathy—Capecitabine—colon cancer	0.000162	0.00054	CcSEcCtD
Aripiprazole—Dyspnoea—Fluorouracil—colon cancer	0.000162	0.00054	CcSEcCtD
Aripiprazole—Somnolence—Fluorouracil—colon cancer	0.000161	0.000538	CcSEcCtD
Aripiprazole—Immune system disorder—Capecitabine—colon cancer	0.000161	0.000538	CcSEcCtD
Aripiprazole—Mediastinal disorder—Capecitabine—colon cancer	0.000161	0.000536	CcSEcCtD
Aripiprazole—Chills—Capecitabine—colon cancer	0.00016	0.000534	CcSEcCtD
Aripiprazole—Dyspepsia—Fluorouracil—colon cancer	0.00016	0.000533	CcSEcCtD
Aripiprazole—Abdominal discomfort—Methotrexate—colon cancer	0.000159	0.000531	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Vincristine—colon cancer	0.000159	0.000531	CcSEcCtD
Aripiprazole—Decreased appetite—Fluorouracil—colon cancer	0.000158	0.000526	CcSEcCtD
Aripiprazole—Alopecia—Capecitabine—colon cancer	0.000158	0.000526	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000157	0.000522	CcSEcCtD
Aripiprazole—Mental disorder—Capecitabine—colon cancer	0.000156	0.000521	CcSEcCtD
Aripiprazole—Feeling abnormal—Irinotecan—colon cancer	0.000156	0.000521	CcSEcCtD
Aripiprazole—Malnutrition—Capecitabine—colon cancer	0.000155	0.000518	CcSEcCtD
Aripiprazole—Erythema—Capecitabine—colon cancer	0.000155	0.000518	CcSEcCtD
Aripiprazole—Dysuria—Methotrexate—colon cancer	0.000155	0.000518	CcSEcCtD
Aripiprazole—Neutropenia—Methotrexate—colon cancer	0.000155	0.000518	CcSEcCtD
Aripiprazole—Pain—Fluorouracil—colon cancer	0.000155	0.000517	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Irinotecan—colon cancer	0.000155	0.000517	CcSEcCtD
Aripiprazole—Upper respiratory tract infection—Methotrexate—colon cancer	0.000154	0.000514	CcSEcCtD
Aripiprazole—Body temperature increased—Vincristine—colon cancer	0.000154	0.000513	CcSEcCtD
Aripiprazole—Abdominal pain—Vincristine—colon cancer	0.000154	0.000513	CcSEcCtD
Aripiprazole—Flatulence—Capecitabine—colon cancer	0.000153	0.000511	CcSEcCtD
Aripiprazole—Erectile dysfunction—Methotrexate—colon cancer	0.000153	0.00051	CcSEcCtD
Aripiprazole—Dysgeusia—Capecitabine—colon cancer	0.000152	0.000507	CcSEcCtD
Aripiprazole—Photosensitivity reaction—Methotrexate—colon cancer	0.000152	0.000505	CcSEcCtD
Aripiprazole—Back pain—Capecitabine—colon cancer	0.00015	0.000501	CcSEcCtD
Aripiprazole—Abdominal pain—Irinotecan—colon cancer	0.00015	0.000499	CcSEcCtD
Aripiprazole—Body temperature increased—Irinotecan—colon cancer	0.00015	0.000499	CcSEcCtD
Aripiprazole—Feeling abnormal—Fluorouracil—colon cancer	0.00015	0.000499	CcSEcCtD
Aripiprazole—Muscle spasms—Capecitabine—colon cancer	0.000149	0.000498	CcSEcCtD
Aripiprazole—Pneumonia—Methotrexate—colon cancer	0.000149	0.000496	CcSEcCtD
Aripiprazole—ABCB1—lymph node—colon cancer	0.000148	0.00135	CbGeAlD
Aripiprazole—Infestation NOS—Methotrexate—colon cancer	0.000148	0.000494	CcSEcCtD
Aripiprazole—Infestation—Methotrexate—colon cancer	0.000148	0.000494	CcSEcCtD
Aripiprazole—Depression—Methotrexate—colon cancer	0.000148	0.000492	CcSEcCtD
Aripiprazole—Vision blurred—Capecitabine—colon cancer	0.000146	0.000488	CcSEcCtD
Aripiprazole—Tremor—Capecitabine—colon cancer	0.000146	0.000485	CcSEcCtD
Aripiprazole—Renal failure—Methotrexate—colon cancer	0.000146	0.000485	CcSEcCtD
Aripiprazole—Stomatitis—Methotrexate—colon cancer	0.000144	0.000481	CcSEcCtD
Aripiprazole—Ill-defined disorder—Capecitabine—colon cancer	0.000144	0.000481	CcSEcCtD
Aripiprazole—Urticaria—Fluorouracil—colon cancer	0.000144	0.000481	CcSEcCtD
Aripiprazole—Conjunctivitis—Methotrexate—colon cancer	0.000144	0.00048	CcSEcCtD
Aripiprazole—Anaemia—Capecitabine—colon cancer	0.000144	0.000479	CcSEcCtD
Aripiprazole—Body temperature increased—Fluorouracil—colon cancer	0.000144	0.000478	CcSEcCtD
Aripiprazole—Hypersensitivity—Vincristine—colon cancer	0.000143	0.000478	CcSEcCtD
Aripiprazole—Sweating—Methotrexate—colon cancer	0.000142	0.000473	CcSEcCtD
Aripiprazole—Haematuria—Methotrexate—colon cancer	0.000141	0.000471	CcSEcCtD
Aripiprazole—Malaise—Capecitabine—colon cancer	0.00014	0.000467	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Methotrexate—colon cancer	0.00014	0.000467	CcSEcCtD
Aripiprazole—Epistaxis—Methotrexate—colon cancer	0.00014	0.000466	CcSEcCtD
Aripiprazole—Vertigo—Capecitabine—colon cancer	0.00014	0.000466	CcSEcCtD
Aripiprazole—Hypersensitivity—Irinotecan—colon cancer	0.00014	0.000466	CcSEcCtD
Aripiprazole—Asthenia—Vincristine—colon cancer	0.00014	0.000465	CcSEcCtD
Aripiprazole—Syncope—Capecitabine—colon cancer	0.000139	0.000465	CcSEcCtD
Aripiprazole—Leukopenia—Capecitabine—colon cancer	0.000139	0.000464	CcSEcCtD
Aripiprazole—Agranulocytosis—Methotrexate—colon cancer	0.000138	0.000461	CcSEcCtD
Aripiprazole—Palpitations—Capecitabine—colon cancer	0.000137	0.000458	CcSEcCtD
Aripiprazole—Loss of consciousness—Capecitabine—colon cancer	0.000137	0.000455	CcSEcCtD
Aripiprazole—Asthenia—Irinotecan—colon cancer	0.000136	0.000453	CcSEcCtD
Aripiprazole—Cough—Capecitabine—colon cancer	0.000136	0.000452	CcSEcCtD
Aripiprazole—Hypertension—Capecitabine—colon cancer	0.000134	0.000447	CcSEcCtD
Aripiprazole—Hypersensitivity—Fluorouracil—colon cancer	0.000134	0.000446	CcSEcCtD
Aripiprazole—Haemoglobin—Methotrexate—colon cancer	0.000134	0.000445	CcSEcCtD
Aripiprazole—Diarrhoea—Vincristine—colon cancer	0.000133	0.000444	CcSEcCtD
Aripiprazole—Haemorrhage—Methotrexate—colon cancer	0.000133	0.000443	CcSEcCtD
Aripiprazole—Hepatitis—Methotrexate—colon cancer	0.000133	0.000443	CcSEcCtD
Aripiprazole—Arthralgia—Capecitabine—colon cancer	0.000132	0.000441	CcSEcCtD
Aripiprazole—Chest pain—Capecitabine—colon cancer	0.000132	0.000441	CcSEcCtD
Aripiprazole—Myalgia—Capecitabine—colon cancer	0.000132	0.000441	CcSEcCtD
Aripiprazole—Pharyngitis—Methotrexate—colon cancer	0.000132	0.00044	CcSEcCtD
Aripiprazole—Anxiety—Capecitabine—colon cancer	0.000132	0.00044	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000131	0.000438	CcSEcCtD
Aripiprazole—Urinary tract disorder—Methotrexate—colon cancer	0.000131	0.000438	CcSEcCtD
Aripiprazole—Discomfort—Capecitabine—colon cancer	0.000131	0.000436	CcSEcCtD
Aripiprazole—Urethral disorder—Methotrexate—colon cancer	0.00013	0.000434	CcSEcCtD
Aripiprazole—Diarrhoea—Irinotecan—colon cancer	0.00013	0.000432	CcSEcCtD
Aripiprazole—Dry mouth—Capecitabine—colon cancer	0.000129	0.000431	CcSEcCtD
Aripiprazole—Dizziness—Vincristine—colon cancer	0.000129	0.000429	CcSEcCtD
Aripiprazole—Pruritus—Fluorouracil—colon cancer	0.000128	0.000428	CcSEcCtD
Aripiprazole—Visual impairment—Methotrexate—colon cancer	0.000128	0.000427	CcSEcCtD
Aripiprazole—Confusional state—Capecitabine—colon cancer	0.000128	0.000426	CcSEcCtD
Aripiprazole—Oedema—Capecitabine—colon cancer	0.000127	0.000423	CcSEcCtD
Aripiprazole—Infection—Capecitabine—colon cancer	0.000126	0.00042	CcSEcCtD
Aripiprazole—Dizziness—Irinotecan—colon cancer	0.000125	0.000418	CcSEcCtD
Aripiprazole—Shock—Capecitabine—colon cancer	0.000125	0.000416	CcSEcCtD
Aripiprazole—Nervous system disorder—Capecitabine—colon cancer	0.000124	0.000415	CcSEcCtD
Aripiprazole—Eye disorder—Methotrexate—colon cancer	0.000124	0.000414	CcSEcCtD
Aripiprazole—Diarrhoea—Fluorouracil—colon cancer	0.000124	0.000414	CcSEcCtD
Aripiprazole—Thrombocytopenia—Capecitabine—colon cancer	0.000124	0.000414	CcSEcCtD
Aripiprazole—Tinnitus—Methotrexate—colon cancer	0.000124	0.000413	CcSEcCtD
Aripiprazole—Tachycardia—Capecitabine—colon cancer	0.000124	0.000413	CcSEcCtD
Aripiprazole—Vomiting—Vincristine—colon cancer	0.000124	0.000413	CcSEcCtD
Aripiprazole—Cardiac disorder—Methotrexate—colon cancer	0.000123	0.000411	CcSEcCtD
Aripiprazole—Skin disorder—Capecitabine—colon cancer	0.000123	0.000411	CcSEcCtD
Aripiprazole—Rash—Vincristine—colon cancer	0.000123	0.000409	CcSEcCtD
Aripiprazole—Hyperhidrosis—Capecitabine—colon cancer	0.000123	0.000409	CcSEcCtD
Aripiprazole—Dermatitis—Vincristine—colon cancer	0.000123	0.000409	CcSEcCtD
Aripiprazole—Headache—Vincristine—colon cancer	0.000122	0.000406	CcSEcCtD
Aripiprazole—Anorexia—Capecitabine—colon cancer	0.000121	0.000403	CcSEcCtD
Aripiprazole—Angiopathy—Methotrexate—colon cancer	0.000121	0.000402	CcSEcCtD
Aripiprazole—Vomiting—Irinotecan—colon cancer	0.000121	0.000402	CcSEcCtD
Aripiprazole—Immune system disorder—Methotrexate—colon cancer	0.00012	0.0004	CcSEcCtD
Aripiprazole—Dizziness—Fluorouracil—colon cancer	0.00012	0.0004	CcSEcCtD
Aripiprazole—Mediastinal disorder—Methotrexate—colon cancer	0.00012	0.000399	CcSEcCtD
Aripiprazole—Rash—Irinotecan—colon cancer	0.00012	0.000398	CcSEcCtD
Aripiprazole—Dermatitis—Irinotecan—colon cancer	0.000119	0.000398	CcSEcCtD
Aripiprazole—Chills—Methotrexate—colon cancer	0.000119	0.000398	CcSEcCtD
Aripiprazole—Headache—Irinotecan—colon cancer	0.000119	0.000396	CcSEcCtD
Aripiprazole—Hypotension—Capecitabine—colon cancer	0.000119	0.000395	CcSEcCtD
Aripiprazole—Alopecia—Methotrexate—colon cancer	0.000117	0.000392	CcSEcCtD
Aripiprazole—Mental disorder—Methotrexate—colon cancer	0.000116	0.000388	CcSEcCtD
Aripiprazole—Malnutrition—Methotrexate—colon cancer	0.000116	0.000386	CcSEcCtD
Aripiprazole—Erythema—Methotrexate—colon cancer	0.000116	0.000386	CcSEcCtD
Aripiprazole—Nausea—Vincristine—colon cancer	0.000116	0.000385	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000116	0.000385	CcSEcCtD
Aripiprazole—Vomiting—Fluorouracil—colon cancer	0.000115	0.000385	CcSEcCtD
Aripiprazole—Insomnia—Capecitabine—colon cancer	0.000115	0.000382	CcSEcCtD
Aripiprazole—Rash—Fluorouracil—colon cancer	0.000114	0.000382	CcSEcCtD
Aripiprazole—Dermatitis—Fluorouracil—colon cancer	0.000114	0.000381	CcSEcCtD
Aripiprazole—Paraesthesia—Capecitabine—colon cancer	0.000114	0.00038	CcSEcCtD
Aripiprazole—Headache—Fluorouracil—colon cancer	0.000114	0.000379	CcSEcCtD
Aripiprazole—Dysgeusia—Methotrexate—colon cancer	0.000113	0.000378	CcSEcCtD
Aripiprazole—Dyspnoea—Capecitabine—colon cancer	0.000113	0.000377	CcSEcCtD
Aripiprazole—Nausea—Irinotecan—colon cancer	0.000113	0.000375	CcSEcCtD
Aripiprazole—Back pain—Methotrexate—colon cancer	0.000112	0.000373	CcSEcCtD
Aripiprazole—Dyspepsia—Capecitabine—colon cancer	0.000112	0.000372	CcSEcCtD
Aripiprazole—Decreased appetite—Capecitabine—colon cancer	0.00011	0.000368	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Capecitabine—colon cancer	0.00011	0.000365	CcSEcCtD
Aripiprazole—Fatigue—Capecitabine—colon cancer	0.000109	0.000365	CcSEcCtD
Aripiprazole—Vision blurred—Methotrexate—colon cancer	0.000109	0.000364	CcSEcCtD
Aripiprazole—Pain—Capecitabine—colon cancer	0.000108	0.000362	CcSEcCtD
Aripiprazole—Constipation—Capecitabine—colon cancer	0.000108	0.000362	CcSEcCtD
Aripiprazole—Nausea—Fluorouracil—colon cancer	0.000108	0.000359	CcSEcCtD
Aripiprazole—Ill-defined disorder—Methotrexate—colon cancer	0.000107	0.000358	CcSEcCtD
Aripiprazole—Anaemia—Methotrexate—colon cancer	0.000107	0.000357	CcSEcCtD
Aripiprazole—Feeling abnormal—Capecitabine—colon cancer	0.000105	0.000348	CcSEcCtD
Aripiprazole—Malaise—Methotrexate—colon cancer	0.000104	0.000348	CcSEcCtD
Aripiprazole—Vertigo—Methotrexate—colon cancer	0.000104	0.000347	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Capecitabine—colon cancer	0.000104	0.000346	CcSEcCtD
Aripiprazole—Leukopenia—Methotrexate—colon cancer	0.000104	0.000345	CcSEcCtD
Aripiprazole—Cough—Methotrexate—colon cancer	0.000101	0.000337	CcSEcCtD
Aripiprazole—Urticaria—Capecitabine—colon cancer	0.000101	0.000336	CcSEcCtD
Aripiprazole—Abdominal pain—Capecitabine—colon cancer	0.0001	0.000334	CcSEcCtD
Aripiprazole—Body temperature increased—Capecitabine—colon cancer	0.0001	0.000334	CcSEcCtD
Aripiprazole—Convulsion—Methotrexate—colon cancer	0.0001	0.000334	CcSEcCtD
Aripiprazole—Myalgia—Methotrexate—colon cancer	9.85e-05	0.000328	CcSEcCtD
Aripiprazole—Chest pain—Methotrexate—colon cancer	9.85e-05	0.000328	CcSEcCtD
Aripiprazole—Arthralgia—Methotrexate—colon cancer	9.85e-05	0.000328	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	9.78e-05	0.000326	CcSEcCtD
Aripiprazole—Discomfort—Methotrexate—colon cancer	9.73e-05	0.000324	CcSEcCtD
Aripiprazole—Confusional state—Methotrexate—colon cancer	9.52e-05	0.000317	CcSEcCtD
Aripiprazole—Anaphylactic shock—Methotrexate—colon cancer	9.44e-05	0.000315	CcSEcCtD
Aripiprazole—Infection—Methotrexate—colon cancer	9.38e-05	0.000313	CcSEcCtD
Aripiprazole—Hypersensitivity—Capecitabine—colon cancer	9.35e-05	0.000312	CcSEcCtD
Aripiprazole—Nervous system disorder—Methotrexate—colon cancer	9.26e-05	0.000309	CcSEcCtD
Aripiprazole—Thrombocytopenia—Methotrexate—colon cancer	9.25e-05	0.000308	CcSEcCtD
Aripiprazole—Skin disorder—Methotrexate—colon cancer	9.17e-05	0.000306	CcSEcCtD
Aripiprazole—Hyperhidrosis—Methotrexate—colon cancer	9.13e-05	0.000304	CcSEcCtD
Aripiprazole—Asthenia—Capecitabine—colon cancer	9.1e-05	0.000303	CcSEcCtD
Aripiprazole—Anorexia—Methotrexate—colon cancer	9e-05	0.0003	CcSEcCtD
Aripiprazole—Pruritus—Capecitabine—colon cancer	8.97e-05	0.000299	CcSEcCtD
Aripiprazole—Hypotension—Methotrexate—colon cancer	8.82e-05	0.000294	CcSEcCtD
Aripiprazole—Diarrhoea—Capecitabine—colon cancer	8.68e-05	0.000289	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Methotrexate—colon cancer	8.6e-05	0.000287	CcSEcCtD
Aripiprazole—Insomnia—Methotrexate—colon cancer	8.54e-05	0.000285	CcSEcCtD
Aripiprazole—Paraesthesia—Methotrexate—colon cancer	8.48e-05	0.000283	CcSEcCtD
Aripiprazole—Dyspnoea—Methotrexate—colon cancer	8.42e-05	0.000281	CcSEcCtD
Aripiprazole—Somnolence—Methotrexate—colon cancer	8.4e-05	0.00028	CcSEcCtD
Aripiprazole—Dizziness—Capecitabine—colon cancer	8.39e-05	0.00028	CcSEcCtD
Aripiprazole—Dyspepsia—Methotrexate—colon cancer	8.31e-05	0.000277	CcSEcCtD
Aripiprazole—Decreased appetite—Methotrexate—colon cancer	8.21e-05	0.000274	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Methotrexate—colon cancer	8.15e-05	0.000272	CcSEcCtD
Aripiprazole—Fatigue—Methotrexate—colon cancer	8.14e-05	0.000271	CcSEcCtD
Aripiprazole—Pain—Methotrexate—colon cancer	8.08e-05	0.000269	CcSEcCtD
Aripiprazole—Vomiting—Capecitabine—colon cancer	8.07e-05	0.000269	CcSEcCtD
Aripiprazole—Rash—Capecitabine—colon cancer	8e-05	0.000267	CcSEcCtD
Aripiprazole—Dermatitis—Capecitabine—colon cancer	7.99e-05	0.000266	CcSEcCtD
Aripiprazole—Headache—Capecitabine—colon cancer	7.95e-05	0.000265	CcSEcCtD
Aripiprazole—Feeling abnormal—Methotrexate—colon cancer	7.78e-05	0.000259	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Methotrexate—colon cancer	7.72e-05	0.000257	CcSEcCtD
Aripiprazole—Nausea—Capecitabine—colon cancer	7.54e-05	0.000251	CcSEcCtD
Aripiprazole—Urticaria—Methotrexate—colon cancer	7.5e-05	0.00025	CcSEcCtD
Aripiprazole—Body temperature increased—Methotrexate—colon cancer	7.47e-05	0.000249	CcSEcCtD
Aripiprazole—Abdominal pain—Methotrexate—colon cancer	7.47e-05	0.000249	CcSEcCtD
Aripiprazole—Hypersensitivity—Methotrexate—colon cancer	6.96e-05	0.000232	CcSEcCtD
Aripiprazole—Asthenia—Methotrexate—colon cancer	6.78e-05	0.000226	CcSEcCtD
Aripiprazole—Pruritus—Methotrexate—colon cancer	6.68e-05	0.000223	CcSEcCtD
Aripiprazole—Diarrhoea—Methotrexate—colon cancer	6.46e-05	0.000215	CcSEcCtD
Aripiprazole—Dizziness—Methotrexate—colon cancer	6.24e-05	0.000208	CcSEcCtD
Aripiprazole—Vomiting—Methotrexate—colon cancer	6e-05	0.0002	CcSEcCtD
Aripiprazole—Rash—Methotrexate—colon cancer	5.95e-05	0.000198	CcSEcCtD
Aripiprazole—Dermatitis—Methotrexate—colon cancer	5.95e-05	0.000198	CcSEcCtD
Aripiprazole—Headache—Methotrexate—colon cancer	5.92e-05	0.000197	CcSEcCtD
Aripiprazole—Nausea—Methotrexate—colon cancer	5.61e-05	0.000187	CcSEcCtD
Aripiprazole—DRD2—Signaling Pathways—CTNNB1—colon cancer	1.58e-06	0.000149	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CASP3—colon cancer	1.58e-06	0.000148	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—PIK3CA—colon cancer	1.58e-06	0.000148	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—VEGFA—colon cancer	1.58e-06	0.000148	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—SRC—colon cancer	1.58e-06	0.000148	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—EP300—colon cancer	1.57e-06	0.000148	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TP53—colon cancer	1.57e-06	0.000148	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CCND1—colon cancer	1.57e-06	0.000148	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CCND1—colon cancer	1.57e-06	0.000147	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—KRAS—colon cancer	1.57e-06	0.000147	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PPARG—colon cancer	1.57e-06	0.000147	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—NRAS—colon cancer	1.57e-06	0.000147	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CCND1—colon cancer	1.56e-06	0.000147	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—NRAS—colon cancer	1.56e-06	0.000146	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CCND1—colon cancer	1.56e-06	0.000146	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CTNNB1—colon cancer	1.56e-06	0.000146	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CTNNB1—colon cancer	1.55e-06	0.000146	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—SRC—colon cancer	1.55e-06	0.000146	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—HRAS—colon cancer	1.55e-06	0.000145	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CTNNB1—colon cancer	1.55e-06	0.000145	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TP53—colon cancer	1.55e-06	0.000145	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—KRAS—colon cancer	1.55e-06	0.000145	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—HRAS—colon cancer	1.55e-06	0.000145	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CDKN1A—colon cancer	1.54e-06	0.000145	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CCND1—colon cancer	1.54e-06	0.000145	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CTNNB1—colon cancer	1.54e-06	0.000145	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CCND1—colon cancer	1.54e-06	0.000145	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—HRAS—colon cancer	1.54e-06	0.000144	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—VEGFA—colon cancer	1.53e-06	0.000144	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CTNNB1—colon cancer	1.53e-06	0.000143	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—PIK3CA—colon cancer	1.53e-06	0.000143	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TP53—colon cancer	1.53e-06	0.000143	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MYC—colon cancer	1.52e-06	0.000143	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—HRAS—colon cancer	1.52e-06	0.000143	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CTNNB1—colon cancer	1.52e-06	0.000143	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TGFB1—colon cancer	1.52e-06	0.000143	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CDKN1A—colon cancer	1.52e-06	0.000143	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CDKN1A—colon cancer	1.52e-06	0.000142	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—NRAS—colon cancer	1.52e-06	0.000142	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CDKN1A—colon cancer	1.51e-06	0.000142	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—PIK3CA—colon cancer	1.51e-06	0.000142	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MYC—colon cancer	1.51e-06	0.000142	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—VEGFA—colon cancer	1.51e-06	0.000142	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TGFB1—colon cancer	1.51e-06	0.000142	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CDKN1A—colon cancer	1.51e-06	0.000142	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—HRAS—colon cancer	1.5e-06	0.000141	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—AKT1—colon cancer	1.5e-06	0.000141	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CDKN1A—colon cancer	1.49e-06	0.00014	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—EGFR—colon cancer	1.49e-06	0.00014	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—NRAS—colon cancer	1.49e-06	0.00014	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CDKN1A—colon cancer	1.49e-06	0.00014	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—AKT1—colon cancer	1.48e-06	0.000139	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—HRAS—colon cancer	1.48e-06	0.000139	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—AKT1—colon cancer	1.48e-06	0.000139	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—EGFR—colon cancer	1.48e-06	0.000139	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TP53—colon cancer	1.48e-06	0.000139	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—AKT1—colon cancer	1.48e-06	0.000139	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—PIK3CA—colon cancer	1.48e-06	0.000139	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ABCB1—colon cancer	1.47e-06	0.000138	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—AKT1—colon cancer	1.47e-06	0.000138	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—EP300—colon cancer	1.47e-06	0.000138	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CASP3—colon cancer	1.47e-06	0.000138	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—AKT1—colon cancer	1.47e-06	0.000138	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TP53—colon cancer	1.46e-06	0.000137	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—HRAS—colon cancer	1.46e-06	0.000137	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MYC—colon cancer	1.46e-06	0.000137	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TGFB1—colon cancer	1.46e-06	0.000137	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—AKT1—colon cancer	1.45e-06	0.000136	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MYC—colon cancer	1.45e-06	0.000136	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—AKT1—colon cancer	1.45e-06	0.000136	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TGFB1—colon cancer	1.45e-06	0.000136	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—TYMS—colon cancer	1.45e-06	0.000136	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—EP300—colon cancer	1.45e-06	0.000136	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—EP300—colon cancer	1.44e-06	0.000136	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—EP300—colon cancer	1.44e-06	0.000135	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—PIK3CA—colon cancer	1.44e-06	0.000135	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—EP300—colon cancer	1.44e-06	0.000135	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—EP300—colon cancer	1.43e-06	0.000135	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—PIK3CA—colon cancer	1.43e-06	0.000135	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CCND1—colon cancer	1.43e-06	0.000134	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—SRC—colon cancer	1.43e-06	0.000134	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—EGFR—colon cancer	1.43e-06	0.000134	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—PIK3CA—colon cancer	1.42e-06	0.000133	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—EP300—colon cancer	1.42e-06	0.000133	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—EGFR—colon cancer	1.42e-06	0.000133	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—EP300—colon cancer	1.42e-06	0.000133	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CTNNB1—colon cancer	1.42e-06	0.000133	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—HRAS—colon cancer	1.41e-06	0.000133	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MYC—colon cancer	1.41e-06	0.000133	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—KRAS—colon cancer	1.41e-06	0.000132	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TGFB1—colon cancer	1.41e-06	0.000132	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—SRC—colon cancer	1.41e-06	0.000132	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—SRC—colon cancer	1.4e-06	0.000132	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—SRC—colon cancer	1.4e-06	0.000131	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—HRAS—colon cancer	1.4e-06	0.000131	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—KRAS—colon cancer	1.4e-06	0.000131	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—SRC—colon cancer	1.39e-06	0.000131	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TP53—colon cancer	1.39e-06	0.000131	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—colon cancer	1.39e-06	0.000131	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MYC—colon cancer	1.39e-06	0.00013	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TGFB1—colon cancer	1.39e-06	0.00013	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CDKN1A—colon cancer	1.38e-06	0.00013	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—SRC—colon cancer	1.38e-06	0.00013	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—EGFR—colon cancer	1.38e-06	0.00013	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—SRC—colon cancer	1.38e-06	0.000129	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NRAS—colon cancer	1.37e-06	0.000129	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TP53—colon cancer	1.37e-06	0.000129	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—colon cancer	1.37e-06	0.000129	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—colon cancer	1.37e-06	0.000128	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—AKT1—colon cancer	1.37e-06	0.000128	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—AKT1—colon cancer	1.36e-06	0.000128	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—colon cancer	1.36e-06	0.000128	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—EGFR—colon cancer	1.36e-06	0.000128	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—colon cancer	1.36e-06	0.000128	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—AKT1—colon cancer	1.36e-06	0.000127	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NRAS—colon cancer	1.35e-06	0.000127	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NRAS—colon cancer	1.35e-06	0.000127	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—KRAS—colon cancer	1.35e-06	0.000127	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—AKT1—colon cancer	1.35e-06	0.000126	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NRAS—colon cancer	1.35e-06	0.000126	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—colon cancer	1.34e-06	0.000126	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NRAS—colon cancer	1.34e-06	0.000126	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—colon cancer	1.34e-06	0.000126	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—KRAS—colon cancer	1.34e-06	0.000126	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—HRAS—colon cancer	1.33e-06	0.000125	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NRAS—colon cancer	1.33e-06	0.000125	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—AKT1—colon cancer	1.33e-06	0.000125	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NRAS—colon cancer	1.32e-06	0.000124	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—EP300—colon cancer	1.32e-06	0.000124	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—HRAS—colon cancer	1.31e-06	0.000123	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—colon cancer	1.31e-06	0.000123	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—AKT1—colon cancer	1.31e-06	0.000123	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—KRAS—colon cancer	1.3e-06	0.000123	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—PIK3CA—colon cancer	1.29e-06	0.000122	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—AKT1—colon cancer	1.29e-06	0.000121	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—KRAS—colon cancer	1.28e-06	0.000121	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—PIK3CA—colon cancer	1.28e-06	0.00012	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MYC—colon cancer	1.28e-06	0.00012	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—SRC—colon cancer	1.28e-06	0.00012	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TGFB1—colon cancer	1.28e-06	0.00012	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—PIK3CA—colon cancer	1.27e-06	0.000119	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MYC—colon cancer	1.26e-06	0.000118	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MYC—colon cancer	1.26e-06	0.000118	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TGFB1—colon cancer	1.26e-06	0.000118	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TGFB1—colon cancer	1.25e-06	0.000118	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MYC—colon cancer	1.25e-06	0.000118	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—EGFR—colon cancer	1.25e-06	0.000118	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TP53—colon cancer	1.25e-06	0.000118	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TGFB1—colon cancer	1.25e-06	0.000117	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MYC—colon cancer	1.25e-06	0.000117	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—AKT1—colon cancer	1.25e-06	0.000117	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TGFB1—colon cancer	1.25e-06	0.000117	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—colon cancer	1.25e-06	0.000117	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TP53—colon cancer	1.24e-06	0.000117	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—PIK3CA—colon cancer	1.24e-06	0.000116	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MYC—colon cancer	1.24e-06	0.000116	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—AKT1—colon cancer	1.23e-06	0.000116	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TGFB1—colon cancer	1.23e-06	0.000116	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MYC—colon cancer	1.23e-06	0.000116	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—colon cancer	1.23e-06	0.000116	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—EGFR—colon cancer	1.23e-06	0.000116	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—PIK3CA—colon cancer	1.23e-06	0.000116	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TGFB1—colon cancer	1.23e-06	0.000116	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NRAS—colon cancer	1.23e-06	0.000116	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—EGFR—colon cancer	1.23e-06	0.000116	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—EGFR—colon cancer	1.23e-06	0.000115	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—EGFR—colon cancer	1.22e-06	0.000115	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—EGFR—colon cancer	1.21e-06	0.000114	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—EGFR—colon cancer	1.21e-06	0.000113	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—AKT1—colon cancer	1.21e-06	0.000113	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—PIK3CA—colon cancer	1.2e-06	0.000113	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TP53—colon cancer	1.2e-06	0.000113	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—HRAS—colon cancer	1.2e-06	0.000113	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TP53—colon cancer	1.19e-06	0.000112	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—HRAS—colon cancer	1.19e-06	0.000111	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—KRAS—colon cancer	1.18e-06	0.000111	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—PIK3CA—colon cancer	1.18e-06	0.000111	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—AKT1—colon cancer	1.18e-06	0.000111	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—AKT1—colon cancer	1.17e-06	0.00011	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—KRAS—colon cancer	1.16e-06	0.000109	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PIK3CA—colon cancer	1.16e-06	0.000109	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—KRAS—colon cancer	1.16e-06	0.000109	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—AKT1—colon cancer	1.16e-06	0.000109	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TP53—colon cancer	1.16e-06	0.000109	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—KRAS—colon cancer	1.16e-06	0.000109	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—KRAS—colon cancer	1.15e-06	0.000108	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MYC—colon cancer	1.15e-06	0.000108	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—HRAS—colon cancer	1.15e-06	0.000108	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TGFB1—colon cancer	1.14e-06	0.000107	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—KRAS—colon cancer	1.14e-06	0.000107	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TP53—colon cancer	1.14e-06	0.000107	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—KRAS—colon cancer	1.14e-06	0.000107	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—HRAS—colon cancer	1.14e-06	0.000107	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—EGFR—colon cancer	1.12e-06	0.000105	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—HRAS—colon cancer	1.11e-06	0.000104	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—HRAS—colon cancer	1.09e-06	0.000102	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—EP300—colon cancer	1.09e-06	0.000102	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—PIK3CA—colon cancer	1.09e-06	0.000102	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—PIK3CA—colon cancer	1.07e-06	0.0001	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—PIK3CA—colon cancer	1.07e-06	0.0001	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PIK3CA—colon cancer	1.07e-06	0.0001	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PIK3CA—colon cancer	1.06e-06	0.0001	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PIK3CA—colon cancer	1.06e-06	9.96e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—KRAS—colon cancer	1.06e-06	9.95e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—AKT1—colon cancer	1.06e-06	9.93e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TP53—colon cancer	1.05e-06	9.88e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PIK3CA—colon cancer	1.05e-06	9.87e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—AKT1—colon cancer	1.05e-06	9.84e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PIK3CA—colon cancer	1.05e-06	9.84e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—AKT1—colon cancer	1.04e-06	9.73e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TP53—colon cancer	1.03e-06	9.72e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TP53—colon cancer	1.03e-06	9.7e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TP53—colon cancer	1.03e-06	9.67e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TP53—colon cancer	1.03e-06	9.64e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—EP300—colon cancer	1.03e-06	9.63e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARG—colon cancer	1.02e-06	9.62e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TP53—colon cancer	1.02e-06	9.55e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TP53—colon cancer	1.01e-06	9.52e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—AKT1—colon cancer	1.01e-06	9.5e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—AKT1—colon cancer	1.01e-06	9.45e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—HRAS—colon cancer	1.01e-06	9.45e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—HRAS—colon cancer	9.9e-07	9.3e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—HRAS—colon cancer	9.88e-07	9.28e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—HRAS—colon cancer	9.84e-07	9.25e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—HRAS—colon cancer	9.81e-07	9.22e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—AKT1—colon cancer	9.79e-07	9.19e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PIK3CA—colon cancer	9.73e-07	9.14e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—HRAS—colon cancer	9.72e-07	9.13e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—HRAS—colon cancer	9.69e-07	9.1e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—AKT1—colon cancer	9.63e-07	9.05e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—AKT1—colon cancer	9.51e-07	8.93e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TP53—colon cancer	9.41e-07	8.84e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—HRAS—colon cancer	9e-07	8.46e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—AKT1—colon cancer	8.88e-07	8.34e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—AKT1—colon cancer	8.74e-07	8.21e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—AKT1—colon cancer	8.72e-07	8.19e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—AKT1—colon cancer	8.71e-07	8.19e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—AKT1—colon cancer	8.69e-07	8.17e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—AKT1—colon cancer	8.66e-07	8.14e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—AKT1—colon cancer	8.58e-07	8.06e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—AKT1—colon cancer	8.56e-07	8.04e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—colon cancer	8.06e-07	7.57e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CA—colon cancer	8.05e-07	7.56e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—AKT1—colon cancer	7.95e-07	7.47e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CA—colon cancer	7.58e-07	7.12e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—EP300—colon cancer	6.7e-07	6.3e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—AKT1—colon cancer	6.57e-07	6.18e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AKT1—colon cancer	6.2e-07	5.82e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CA—colon cancer	4.96e-07	4.66e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AKT1—colon cancer	4.05e-07	3.81e-05	CbGpPWpGaD
